journal article·2024-02Open access

Green‐Prepared Magnesium Silicate Sprays Enhance the Repair of Burn‐Skin Wound and Appendages Regeneration in Rats and Minipigs

Shunxiang Xu, Yuantao Zhang, Bingyang Dai, Jiancun Rao, Fanyan Deng, Shi'an Zhang, Hongwei Shao, Xu Li, Zheyu Jin, Tongzhou Liang, Yongkang Yang, Yucong Li, Ziyi Chen, Wenxue Tong, Jiankun Xu, Congqin Ning, Ling Qin

Advanced Functional Materials· Volume 34· Issue 9

Abstract

Abstract Bioceramics provide promising tactics for wound healing, yet the on‐shelf products are still unmet, especially for skin appendages regeneration. Herein, the inorganic magnesium silicate sprays (MSS) as mineral factors to overcome the existing challenges is proposed. Results indicate MSS can be synthesized by a green method without organic solvents, templates, calcination, and harmful by‐products. With amorphous phase, nanoscale, and high specific surface area, MSS reveal an improved pH‐responsive degradability and excellent bioactivity for cell proliferation and migration. In rats, MSS display a dose‐dependent effect on accelerating burn‐wound repair via regulating the expressions of iNOS and IL‐10 to attenuate inflammation, elevating the expressions of CD31 and α‐SMA to improve vascularization, and boosting collagen deposition without ectopic calcification. The released Mg and Si ions synergistically potentiate the expressions of Gap43, Tubb3, and K19, suggesting the regeneration of peripheral nerves and hair follicles. These superior features are further verified by comparisons with commercial products, Dermlin® and 45S5 bioglass®, in both rats and minipigs. Motivated by these findings, three MSS‐based formulations of band‐aid patch, adhesive hydrogel, and antibacterial sprays are devised for specific scenarios. Taken together, this proof‐of concept study provides a promising bioactive mineral for future clinical skin wound repair and functional appendages regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Therapeutic Uses of Natural Elements · Burn Injury Management and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Musculoskeletal Research Laboratory Department of Orthopaedics & Traumatology Faculty of Medicine The Chinese University of Hong Kong Hong Kong SAR 999077 P. R. China

Innovative Orthopedic Biomaterial and Drug Translational Research Laboratory Li Ka Shing Institute of Health Sciences Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong SAR 999077 P. R. China

Advanced Imaging and Microscopy (AIM) Lab of Nano Center University of Maryland College Park MD 20742 USA

The Education Ministry Key Lab of Resource Chemistry and Shanghai Frontiers Science Center of Biomimetic Catalysis and Shanghai Engineering Research Center of Green Energy Chemical Engineering Shanghai Normal University Shanghai 200234 P. R. China

References (76)

Show source-provided references
1. World Health Organization https://www.who.int/.
2. 10.1016/j.addr.2017.09.01810.1016/j.addr.2017.09.018 ↗
3. Antrum J. · BMJ · 2022 · 37910.1136/bmj-2021-068812 ↗
4. 10.1186/s12967-020-02248-510.1186/s12967-020-02248-5 ↗
5. 10.1038/s41572-020-0145-510.1038/s41572-020-0145-5 ↗
6. 10.1001/jama.2018.1242610.1001/jama.2018.12426 ↗
7. 10.1002/EXP.2021008310.1002/EXP.20210083 ↗
8. 10.1021/acsabm.2c0038410.1021/acsabm.2c00384 ↗
9. 10.1039/C7TB01211J10.1039/C7TB01211J ↗
10. 10.1111/iwj.1326110.1111/iwj.13261 ↗
11. 10.1016/j.ijsu.2018.02.03610.1016/j.ijsu.2018.02.036 ↗
12. 10.1016/j.actbio.2014.11.00410.1016/j.actbio.2014.11.004 ↗
13. 10.1039/C8TB02938E10.1039/C8TB02938E ↗
14. 10.1016/j.apmt.2018.03.00110.1016/j.apmt.2018.03.001 ↗
15. 10.1016/j.mattod.2022.01.01910.1016/j.mattod.2022.01.019 ↗
16. 10.1016/j.mattod.2018.07.01610.1016/j.mattod.2018.07.016 ↗
17. 10.1172/JCI3595710.1172/JCI35957 ↗
18. 10.1039/C7TB01221G10.1039/C7TB01221G ↗
19. 10.1016/j.actbio.2020.08.01410.1016/j.actbio.2020.08.014 ↗
20. 10.1186/s12967-020-02248-510.1186/s12967-020-02248-5 ↗
21. Dai B. · Bioact. Mater. · 2021 · 8 · 2511
22. 10.1002/advs.20190244310.1002/advs.201902443 ↗
23. 10.1002/jbm.a.3745310.1002/jbm.a.37453 ↗
24. 10.1016/j.jot.2021.07.00610.1016/j.jot.2021.07.006 ↗
25. 10.1002/advs.20220210210.1002/advs.202202102 ↗
26. 10.4161/psb.2972010.4161/psb.29720 ↗
27. 10.5114/pm.2016.5877610.5114/pm.2016.58776 ↗
28. 10.1152/physrev.00012.201410.1152/physrev.00012.2014 ↗
29. 10.1002/adhm.20190046310.1002/adhm.201900463 ↗
30. 10.1038/s41598-021-02930-810.1038/s41598-021-02930-8 ↗
31. 10.1016/j.msec.2017.02.10010.1016/j.msec.2017.02.100 ↗
32. 10.1016/j.apmt.2020.10077710.1016/j.apmt.2020.100777 ↗
33. 10.1016/j.cej.2020.12710610.1016/j.cej.2020.127106 ↗
34. 10.1016/j.msec.2017.03.23610.1016/j.msec.2017.03.236 ↗
35. 10.1021/cr400366s10.1021/cr400366s ↗
36. 10.1111/exd.1404610.1111/exd.14046 ↗
37. 10.1016/j.burns.2014.10.02310.1016/j.burns.2014.10.023 ↗
38. Luo M. · Bioact. Mater. · 2023 · 25 · 319
39. 10.1016/j.msec.2015.11.06810.1016/j.msec.2015.11.068 ↗
40. 10.1038/s41598-021-03855-y10.1038/s41598-021-03855-y ↗
41. Wang X. · Smart Med · 2022 · 1
42. 10.3389/fbioe.2021.61378710.3389/fbioe.2021.613787 ↗
43. Yuan Z. · Adv. Funct. Mater. · 2022 · 32
44. 10.1039/C5TB02632F10.1039/C5TB02632F ↗
45. 10.1039/C7RA08766G10.1039/C7RA08766G ↗
46. 10.1021/acssuschemeng.7b0014010.1021/acssuschemeng.7b00140 ↗
47. 10.1021/ar100145710.1021/ar1001457 ↗
48. 10.1002/adma.20210347710.1002/adma.202103477 ↗
49. Rashid I. · Excip. Relat. Methodol. · 2011 · 36 · 241
50. 10.3390/ma1320462110.3390/ma13204621 ↗
51. 10.1161/CIRCRESAHA.118.31466910.1161/CIRCRESAHA.118.314669 ↗
52. 10.1016/j.compositesb.2021.10956910.1016/j.compositesb.2021.109569 ↗
53. 10.1016/j.smaim.2022.01.00110.1016/j.smaim.2022.01.001 ↗
54. Zhang H. · Adv. Healthcare Mater. · 2022 · 11
55. 10.1002/EXP.2021008310.1002/EXP.20210083 ↗
56. 10.1002/jbm.a.3715410.1002/jbm.a.37154 ↗
57. 10.1016/j.bioactmat.2022.06.01810.1016/j.bioactmat.2022.06.018 ↗
58. Takeo M. · CSH Perspect. Med. · 2015 · 5
59. 10.3389/fcell.2021.71785410.3389/fcell.2021.717854 ↗
60. 10.1007/978-94-007-7500-8_310.1007/978-94-007-7500-8_3 ↗
61. 10.1016/j.bioactmat.2020.12.00610.1016/j.bioactmat.2020.12.006 ↗
62. 10.1016/j.actbio.2020.08.01410.1016/j.actbio.2020.08.014 ↗
63. 10.1186/s11658-021-00277-610.1186/s11658-021-00277-6 ↗
64. 10.1007/s10534-021-00328-710.1007/s10534-021-00328-7 ↗
65. Li Q. · Am. J. Pathol. · 2013 · 183
66. Yu L. · Small · 2018 · 14
67. ISO 10993–5 Biological Evaluation of Medical Devices‐Part 5: Tests for in Vitro Cytotoxicity2009.
68. 10.1016/j.biomaterials.2022.12175110.1016/j.biomaterials.2022.121751 ↗
69. 10.3389/fbioe.2018.0009910.3389/fbioe.2018.00099 ↗
70. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
71. 10.1007/s00018-014-1612-510.1007/s00018-014-1612-5 ↗
72. 10.1038/mtm.2016.4110.1038/mtm.2016.41 ↗
73. 10.1038/s41598-021-03855-y10.1038/s41598-021-03855-y ↗
74. 10.1021/acsnano.2c0474710.1021/acsnano.2c04747 ↗
75. 10.1016/j.biomaterials.2020.12055310.1016/j.biomaterials.2020.120553 ↗
76. 10.1016/j.msec.2020.11149310.1016/j.msec.2020.111493 ↗